Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
https://bioceoandinvestorconference19.azurewebsites.net/
Resverlogix Tuesday Feb 12th 2:00 to 2:15 PM
Zenith Tuesday Feb 12th 2:30 to 2:45 PM
Thanks forĀ posting over on IV rndtbl.